vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and MODIV INDUSTRIAL, INC. (MDV). Click either name above to swap in a different company.

IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $11.1M, roughly 1.3× MODIV INDUSTRIAL, INC.). On growth, MODIV INDUSTRIAL, INC. posted the faster year-over-year revenue change (-5.6% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs -3.8%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.

IRIX vs MDV — Head-to-Head

Bigger by revenue
IRIX
IRIX
1.3× larger
IRIX
$14.7M
$11.1M
MDV
Growing faster (revenue YoY)
MDV
MDV
+64.2% gap
MDV
-5.6%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
-3.8%
MDV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRIX
IRIX
MDV
MDV
Revenue
$14.7M
$11.1M
Net Profit
$1.2M
Gross Margin
37.2%
Operating Margin
45.8%
Net Margin
11.0%
Revenue YoY
-69.7%
-5.6%
Net Profit YoY
-22.0%
EPS (diluted)
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
MDV
MDV
Q4 25
$14.7M
$11.1M
Q3 25
$12.5M
$11.7M
Q2 25
$13.6M
$11.8M
Q1 25
$11.9M
$11.8M
Q4 24
$12.7M
$11.7M
Q3 24
$11.6M
$11.7M
Q2 24
$12.6M
$11.4M
Q1 24
$11.8M
$12.0M
Net Profit
IRIX
IRIX
MDV
MDV
Q4 25
$1.2M
Q3 25
$-1.6M
$1.0M
Q2 25
$-994.0K
$-2.0M
Q1 25
$-1.7M
$829.0K
Q4 24
$-834.0K
$1.6M
Q3 24
$-1.9M
$-587.0K
Q2 24
$-2.7M
$1.3M
Q1 24
$-3.5M
$3.7M
Gross Margin
IRIX
IRIX
MDV
MDV
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
MDV
MDV
Q4 25
45.8%
Q3 25
-11.3%
41.4%
Q2 25
-6.9%
9.8%
Q1 25
-1.7%
40.2%
Q4 24
-3.9%
45.4%
Q3 24
-16.1%
42.0%
Q2 24
-20.9%
44.6%
Q1 24
-28.0%
55.6%
Net Margin
IRIX
IRIX
MDV
MDV
Q4 25
11.0%
Q3 25
-12.6%
9.0%
Q2 25
-7.3%
-17.1%
Q1 25
-14.2%
7.0%
Q4 24
-6.6%
13.3%
Q3 24
-16.7%
-5.0%
Q2 24
-21.2%
11.6%
Q1 24
-29.5%
31.1%
EPS (diluted)
IRIX
IRIX
MDV
MDV
Q4 25
$0.02
Q3 25
$-0.09
$0.00
Q2 25
$-0.06
$-0.32
Q1 25
$-0.10
$-0.01
Q4 24
$-0.05
$0.07
Q3 24
$-0.12
$-0.18
Q2 24
$-0.16
$0.03
Q1 24
$-0.21
$0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
MDV
MDV
Cash + ST InvestmentsLiquidity on hand
$6.0M
$14.4M
Total DebtLower is stronger
$261.5M
Stockholders' EquityBook value
$162.7M
Total Assets
$29.2M
$476.5M
Debt / EquityLower = less leverage
1.61×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
MDV
MDV
Q4 25
$6.0M
$14.4M
Q3 25
$5.6M
$8.3M
Q2 25
$6.8M
$5.8M
Q1 25
$7.2M
$6.2M
Q4 24
$2.4M
$11.5M
Q3 24
$3.9M
$6.8M
Q2 24
$4.1M
$18.9M
Q1 24
$5.4M
$18.4M
Total Debt
IRIX
IRIX
MDV
MDV
Q4 25
$261.5M
Q3 25
$279.7M
Q2 25
$279.7M
Q1 25
$279.7M
Q4 24
$1.0M
$279.8M
Q3 24
$1.4M
$279.7M
Q2 24
$279.7M
Q1 24
$279.6M
Stockholders' Equity
IRIX
IRIX
MDV
MDV
Q4 25
$162.7M
Q3 25
$4.7M
$164.8M
Q2 25
$6.1M
$165.6M
Q1 25
$852.0K
$171.1M
Q4 24
$2.1M
$190.1M
Q3 24
$2.6M
$186.3M
Q2 24
$4.2M
$187.0M
Q1 24
$6.5M
$188.0M
Total Assets
IRIX
IRIX
MDV
MDV
Q4 25
$29.2M
$476.5M
Q3 25
$28.4M
$499.6M
Q2 25
$31.6M
$498.9M
Q1 25
$34.2M
$506.8M
Q4 24
$29.1M
$507.8M
Q3 24
$30.2M
$507.4M
Q2 24
$31.2M
$519.5M
Q1 24
$34.1M
$522.5M
Debt / Equity
IRIX
IRIX
MDV
MDV
Q4 25
1.61×
Q3 25
1.70×
Q2 25
1.69×
Q1 25
1.63×
Q4 24
0.48×
1.47×
Q3 24
0.53×
1.50×
Q2 24
1.50×
Q1 24
1.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
MDV
MDV
Operating Cash FlowLast quarter
$15.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
12.34×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
MDV
MDV
Q4 25
$15.0M
Q3 25
$-1.2M
$4.1M
Q2 25
$-397.0K
$3.9M
Q1 25
$-1.1M
$3.0M
Q4 24
$-1.2M
$18.2M
Q3 24
$-3.1M
$5.1M
Q2 24
$-1.3M
$4.7M
Q1 24
$-1.6M
$3.0M
Free Cash Flow
IRIX
IRIX
MDV
MDV
Q4 25
Q3 25
$-1.2M
Q2 25
$-410.0K
Q1 25
$-1.2M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
Q1 24
$-1.7M
FCF Margin
IRIX
IRIX
MDV
MDV
Q4 25
Q3 25
-9.4%
Q2 25
-3.0%
Q1 25
-9.8%
Q4 24
-9.8%
Q3 24
-26.5%
Q2 24
Q1 24
-14.0%
Capex Intensity
IRIX
IRIX
MDV
MDV
Q4 25
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
IRIX
IRIX
MDV
MDV
Q4 25
12.34×
Q3 25
3.95×
Q2 25
Q1 25
3.68×
Q4 24
11.72×
Q3 24
Q2 24
3.55×
Q1 24
0.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons